Hwang, B.-J., Tsao, L.-C., DeLeon, G., Wei, J., Yang, X.-Y., Lei, G., … Hartman, Z. C. (2020). PR2 Overexpression of MAVS stimulates antitumor immunity and significantly reduces tumor growth of immune-insensitive colorectal cancer in vivo. In CANCER IMMUNOLOGY RESEARCH (Vol. 8, pp. 53–54). AMER ASSOC CANCER RESEARCH.

Hwang, Bin-Jin, Li-Chung Tsao, Gabriel DeLeon, Junping Wei, Xiao-Yi Yang, Gangjun Lei, Tao Wang, Michael M. Morse, Herbert Kim Lyerly, and Zachary Conrad Hartman. “PR2 Overexpression of MAVS stimulates antitumor immunity and significantly reduces tumor growth of immune-insensitive colorectal cancer in vivo.” In CANCER IMMUNOLOGY RESEARCH, 8:53–54. AMER ASSOC CANCER RESEARCH, 2020.

Hwang B-J, Tsao L-C, DeLeon G, Wei J, Yang X-Y, Lei G, et al. PR2 Overexpression of MAVS stimulates antitumor immunity and significantly reduces tumor growth of immune-insensitive colorectal cancer in vivo. In: CANCER IMMUNOLOGY RESEARCH. AMER ASSOC CANCER RESEARCH; 2020. p. 53–4.

Hwang, Bin-Jin, et al. “PR2 Overexpression of MAVS stimulates antitumor immunity and significantly reduces tumor growth of immune-insensitive colorectal cancer in vivo.” CANCER IMMUNOLOGY RESEARCH, vol. 8, no. 3, AMER ASSOC CANCER RESEARCH, 2020, pp. 53–54.

Hwang B-J, Tsao L-C, DeLeon G, Wei J, Yang X-Y, Lei G, Wang T, Morse MM, Lyerly HK, Hartman ZC. PR2 Overexpression of MAVS stimulates antitumor immunity and significantly reduces tumor growth of immune-insensitive colorectal cancer in vivo. CANCER IMMUNOLOGY RESEARCH. AMER ASSOC CANCER RESEARCH; 2020. p. 53–54.